A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.
In a new study, Scripps Institution of Oceanography climate scientists Amato Evan and Ian Eisenman identify regional variations in snowpack melt as temperatures increase, and they present a theory that explains which mountain snowpacks worldwide are most “at-risk” from climate change.
Recent world events, including the election of President Joe Biden, the global COVID-19 pandemic and more, have many wondering, “What’s next on the world stage?”
UC San Diego was awarded five COVID-19 Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health totaling nearly $33 million, which will fund efforts that range from managing a large data center to expanding testing in disadvantaged communities.
UC San Diego School of Medicine researchers are using stem cell-derived organoids to study how SARS-CoV-2 interacts with various organ systems. Their findings may help explain the wide variety in COVID-19 symptoms and aid the search for therapies.